2 July 2015
ABOUT ZETA FRACTION PROCESS AND TECHNOLOGY
The patented Zeta Fraction process and technology
selectively isolates efficacious components
from living plants and marine sources
to produce a wide range of biofunctional ingredients.
Targeted cellular fractions are gently separated
based on unique patented technology,
preserving the inherent value of the plant cell juice.
Conventional plant extraction technology
isolates botanical extracts from dried plants and
uses external solvents that limit shelf life stability
and reproducibility, among other limitations.
VIEW ZETA FRACTION TECHNOLOGY BROCHURE
Recentia™, Zeta Fraction™ and Tomorrow’s Answers
Today® are trademarks of one or more Akzo Nobel Companies.
DETAILS
Ashland Specialty Ingredients,
a commercial unit of Ashland Inc. (NYSE: ASH)
and a world leader in the production of biofunctional ingredients,
today announced it has signed a definitive agreement
to purchase the Zeta Fraction technology from AkzoNobel.
The acquisition broadens Ashland's value-added portfolio
in the personal care, pharmaceutical, food and beverage,
and agriculture markets.
The transaction is expected to be completed
during the current fiscal quarter.
Financial terms were not disclosed.
The Zeta Fraction technology, when combined with
Ashland's ongoing work and recent investments in biofunctionals,
will better position the company
for growth in the natural-based specialty ingredients market.
WWW.CHEMWINFO.COM BY KHUN PHICHAI
